ZOMETA International Site for Healthcare Professionals Outside of the US

US Residents

Italiano

Français

Español

Deutsch

- MOA in Advanced Solid Tumours and MM
- ZOMETA European SmPC

Site Guide

This is an international site for Zometa^® (zoledronic acid) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.

Zometa Information for US residents Zometa Information for Patients Outside the US

Welcome to the ZOMETA Product Website

ZOMETA is approved for use in
95 countries
around the world.

ZOMETA Country-Level Websites

Below is a list of the countries that host a ZOMETA website based on local label and in local language. They are intended for Healthcare Professional (HCPs) only. Click on any of the links to be redirected to that country-level website.

ZOMETA International Website

This website is intended for Healthcare Professionals (HCPs) outside the U.S. The information on this website is not country specific and may contain information that is outside the approved indication in the country in which you are located. Please contact your local representative for local prescribing information via www.novartisoncology.com/contactus .

IMPORTANT: The information on this website is based on the European Summary of Product Characteristics (EUSmPC)

Email

|

|

Text size:

ZOMETA Home

ZOMETA in Advanced Cancers

Protection Across Advanced Malignancies

Prostate Cancer

Multiple Myeloma

Renal Cell Carcinoma

Tumour-Induced Hypercalcaemia
ZOMETA European SmPC

ZOMETA in Multiple Myeloma

Threat of Skeletal-Related Events

ZOMETA Efficacy in Multiple Myeloma Involving Bone

ZOMETA European SmPC

ZOMETA Dosing and Administration

Advanced Solid Tumours and Multiple Myeloma

Tumour-Induced Hypercalcaemia
ZOMETA Formulations
Renal Safety Guidelines
Ready To Use Instructional Videos
ZOMETA European SmPC

ZOMETA Safety and Tolerability

Multiple Myeloma/Advanced Solid Tumours
Osteonecrosis Of The Jaw (ONJ)
ZOMETA European SmPC

ZOMETA MOA

MOA In Advanced Solid Tumours and Multiple Myeloma
ZOMETA European SmPC

Resources

Creatinine Clearance Calculator
Case Studies

Resource Center

ZOMETA European SmPC

Summary of Product Characteristics

Home | ZOMETA in Advanced Cancers | ZOMETA in Multiple Myeloma | ZOMETA Dosing and Administration | ZOMETA Safety and Tolerability
ZOMETA Mechanism of Action (MOA) | Resources | Summary of Product Characteristics

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

About Novartis Oncology | Site Guide | Contact Us

Use of this website is subject to our Terms of Use and Privacy Statement
© Novartis AG.